First international external quality assessment for hepatitis delta virus RNA quantification in plasma

Hepatology

Volumn 64, Issue 5, 2016, Pages 1483-1494

  Le Gal, Frédéric ^a,b   Brichler, Ségolène ^a,b,c   Sahli, Roland ^d   Chevret, Sylvie ^e   Gordien, Emmanuel ^a,b,c  

^a University Hospitals of Paris Seine Saint Denis   (France)

^b C and Delta in France   (France)

^c INSERM U955   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; HEPATITIS DELTA ANTIGEN; VIRUS RNA;

ACCURACY; ARTICLE; CONTROLLED STUDY; DILUTION; DISPERSION; GENETIC VARIABILITY; HEPATITIS DELTA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS GENOME; VIRUS LOAD; BLOOD; BLOOD EXAMINATION; CLINICAL TRIAL; GENETICS; HUMAN; INTERNATIONAL COOPERATION; LABORATORY; MULTICENTER STUDY; STANDARDS;

HEMATOLOGIC TESTS; HEPATITIS DELTA VIRUS; HUMANS; INTERNATIONAL COOPERATION; LABORATORIES; QUALITY CONTROL; RNA, VIRAL;

EID: 84989315128     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28772     Document Type: Article

References (34)

1. Fattovich G, Boscaro S, Noventa F, Pornaro E, Stenico D, Alberti A, et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987;155:931–935.
2. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000;46:420–426.
3. Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, et al. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study. J Hepatol 2013;59:949–956.
4. Noureddin M, Gish R. Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery. Curr Gastroenterol Rep 2014;16:365.
5. Williams V, Brichler S, Khan E, Chami M, Deny P, Kremsdorf D, Gordien E. Large hepatitis delta antigen activates STAT-3 and NF-kappaB via oxidative stress. J Viral Hepat 2012;19:744–753.
6. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009;136:1629–1638.
7. Romeo R, Foglieni B, Casazza G, Spreafico M, Colombo M, Prati D. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta. PLoS One 2014;9:e92062.
8. Buti M, Homs M, Rodriguez-Frias F, Funalleras G, Jardi R, Sauleda S, et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat 2011;18:434–442.
9. Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015;7:777–786.
10. Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 2006;44:713–720.
11. Koh C, Canini L, Dahari H, Zhao X, Uprichard SL, Haynes-Williams V, et al. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. Lancet Infect Dis 2015;15:1167–1174.
12. Urban S, Bartenschlager R, Kubitz R, Zoulim F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 2014;147:48–64.
13. Noordeen F, Scougall CA, Grosse A, Qiao Q, Ajilian BB, Reaiche-Miller G, et al. Therapeutic antiviral effect of the nucleic acid polymer REP 2055 against persistent duck hepatitis B virus infection. PLoS One 2015;10:e0140909.
14. Rizzetto M. The adventure of delta. Liver Int 2016;36(Suppl 1):135–140.
15. Romeo R, Perbellini R. Hepatitis delta virus: Making the point from virus isolation up to 2014. World J Hepatol 2015;7:2389–2395.
16. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015;386:1546–1555.
17. Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, Deny P. Eighth major clade for hepatitis delta virus. Emerg Infect Dis 2006;12:1447–1450.
18. Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004;78:2537–2544.
19. Le Gal F, Gordien E, Affolabi D, Hanslik T, Alloui C, Deny P, Gault E. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 2005;43:2363–2369.
20. Botelho-Souza LF, dos Santos Ade O, Borzacov LM, Honda ER, Villalobos-Salcedo JM, Vieira DS. Development of a reverse transcription quantitative real-time PCR-based system for rapid detection and quantitation of hepatitis delta virus in the western Amazon region of Brazil. J Virol Methods 2014;197:19–24.
21. Ferns RB, Nastouli E, Garson JA. Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard. J Virol Methods 2012;179:189–194.
22. Hofmann J, Frenzel K, Minh BQ, von Haeseler A, Edelmann A, Ross SR, et al. Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis. Diagn Microbiol Infect Dis 2010;67:172–179.
23. Karatayli E, Altunoglu YC, Karatayli SC, Alagoz SG, Cinar K, Yalcin K, et al. A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control. J Clin Virol 2014;60:11–15.
24. Katsoulidou A, Manesis E, Rokka C, Issaris C, Pagoni A, Sypsa V, Hatzakis A. Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D. J Viral Hepat 2013;20:256–262.
25. Kodani M, Martin A, Mixson-Hayden T, Drobeniuc J, Gish RR, Kamili S. One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA. J Virol Methods 2013;193:531–535.
26. Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, Bock T, et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 2010;48:2022–2029.
27. Scholtes C, Icard V, Amiri M, Chevallier-Queyron P, Trabaud MA, Ramiere C, et al. Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA. J Clin Microbiol 2012;50:2126–2128.
28. Shang D, Hughes SA, Horner M, Bruce MJ, Dong Y, Carey I, et al. Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population. J Virol Methods 2012;184:55–62.
29. Yamashiro T, Nagayama K, Enomoto N, Watanabe H, Miyagi T, Nakasone H, et al. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction—and its possible correlation with the clinical stage of liver disease. J Infect Dis 2004;189:1151–1157.
30. Brichler S, Le Gal F, Butt A, Chevret S, Gordien E. Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia. Clin Gastroenterol Hepatol 2013;11:734–740.
31. Brichler S, Le Gal F, Neri-Pinto F, Mansour W, Roulot D, Laperche S, Gordien E. Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study. J Clin Microbiol 2014;52:1694–1697.
32. Jeng KS, Daniel A, Lai MM. A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication. J Virol 1996;70:2403–2410.
33. Taylor JM. Hepatitis D Virus replication. Cold Spring Harb Perspect Med 2015;5. pii: a021568. doi: 10.1101/cshperspect.a021568.
34. Homs M, Giersch K, Blasi M, Lutgehetmann M, Buti M, Esteban R, et al. Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification. J Clin Microbiol 2014;52:3334–3338.